资讯

PsyPost on MSN3 个月
Nicotinamide trial for Alzheimer’s disease shows no clear benefit in reducing tau proteins
Nicotinamide emerged as a candidate for investigation ... The treatment was administered in the form of sustained-release ...
Yahoo Finance22 天
Niagen Bioscience Secures U.S. Patent for the Composition of Matter for Nicotinamide ...
(NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the broadening of its NAD+ ...